Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS.

POU5F1 (more commonly known as OCT4/3) is one of the stem cell markers, and affects direction of differentiation in embryonic stem cells. To investigate whether cells of mesenchymal origin acquire embryonic phenotypes, we generated human cells of mesodermal origin with overexpression of the chimeric OCT4/3 gene with physiological co-activator EWS (product of the EWSR1 gene), which is driven by the potent EWS promoter by translocation. The cells expressed embryonic stem cell genes such as NANOG, lost mesenchymal phenotypes, and exhibited embryonal stem cell-like alveolar structures when implanted into the subcutaneous tissue of immunodeficient mice. Hierarchical analysis by microchip analysis and cell surface analysis revealed that the cells are subcategorized into the group of human embryonic stem cells and embryonal carcinoma cells. These results imply that cells of mesenchymal origin can be traced back to cells of embryonic phenotype by the OCT4/3 gene in collaboration with the potent cis-regulatory element and the fused co-activator. The cells generated in this study with overexpression of chimeric OCT4/3 provide us with insight into cell plasticity involving OCT4/3 that is essential for embryonic cell maintenance, and the complexity required for changing cellular identity.

[1]  K. Okamoto,et al.  A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells , 1990, Cell.

[2]  O. Lee,et al.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood. , 2004, Blood.

[3]  K. Artzt,et al.  Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. , 1996, The Journal of biological chemistry.

[4]  L. Shaffer,et al.  Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities , 1997, Human Genetics.

[5]  M. Toyoda,et al.  Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor Cells , 2008, Molecular and Cellular Biology.

[6]  T. Ishida,et al.  Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. , 1997, The American journal of pathology.

[7]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[8]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[9]  Jungho Kim,et al.  Stimulation of Oct‐4 Activity by Ewing's Sarcoma Protein , 2005, Stem cells.

[10]  J. Hata,et al.  In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. , 2003, Experimental cell research.

[11]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[12]  N. Socci,et al.  Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells , 2005, PLoS medicine.

[13]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[14]  J. Kononen,et al.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.

[15]  T. Kiyono,et al.  Combination of hTERT and bmi-1, E6, or E7 Induces Prolongation of the Life Span of Bone Marrow Stromal Cells from an Elderly Donor without Affecting Their Neurogenic Potential , 2005, Molecular and Cellular Biology.

[16]  D. Rappolee,et al.  Expression of transcription regulating genes in human preimplantation embryos , 1995 .

[17]  T. Sugiyama,et al.  Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis. , 2003, Experimental cell research.

[18]  H. Schöler,et al.  Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation , 1998, Mechanisms of Development.

[19]  J. Hata,et al.  Neurogenic potential of Ewing's sarcoma cells , 2005, Virchows Archiv.

[20]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[21]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[22]  S. Ichinose,et al.  Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. , 2006, Biochemical and biophysical research communications.

[23]  F. Lund-Johansen,et al.  The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. , 1995, Blood.

[24]  K. Segawa,et al.  The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells In Vitro , 2007, Stem cells.

[25]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[26]  S. Kyo,et al.  Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. , 2007, Molecular biology of the cell.

[27]  A. Akatsuka,et al.  EAT/mcl-1 expression in the human embryonal carcinoma cells undergoing differentiation or apoptosis. , 2001, Experimental cell research.

[28]  A. Sadikot,et al.  Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.

[29]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[30]  T. Kiyono,et al.  Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. , 2005, Molecular biology of the cell.

[31]  C. Rodeck,et al.  Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. , 1999, Molecular human reproduction.

[32]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[33]  E. Ishii,et al.  DIFFERENTIATION OF HUMAN GERM CELL TUMOR CELLS IN VIVO AND IN VITRO , 1992 .

[34]  H. Schöler,et al.  Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. , 1994, Developmental biology.

[35]  G. Childs,et al.  The Transcriptional Repressor ZFM1 Interacts with and Modulates the Ability of EWS to Activate Transcription* , 1998, The Journal of Biological Chemistry.

[36]  H. Schöler,et al.  Oct‐4: a germline‐specific transcription factor mapping to the mouse t‐complex. , 1990, The EMBO journal.

[37]  M. Nieto,et al.  Snail family members and cell survival in physiological and pathological cleft palates. , 2004, Developmental biology.

[38]  M. Tada,et al.  Histone Code Modifications on Pluripotential Nuclei of Reprogrammed Somatic Cells , 2004, Molecular and Cellular Biology.

[39]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[40]  H. Ohgushi,et al.  Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. , 2008, Experimental cell research.

[41]  T. Martin,et al.  Differentiation potential of a mouse bone marrow stromal cell line , 2003, Journal of cellular biochemistry.

[42]  G. Perrière,et al.  Physiological oxygenation status is required for fully differentiated phenotype in kidney cortex proximal tubules. , 2006, American journal of physiology. Renal physiology.

[43]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[44]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[45]  Peter W. J. Rigby,et al.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo , 1990, Nature.

[46]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[47]  M. Pera,et al.  Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2. , 1998, Reproduction, fertility, and development.

[48]  D. Steindler,et al.  Mesenchymal Stem Cells Spontaneously Express Neural Proteins in Culture and Are Neurogenic after Transplantation , 2006, Stem cells.

[49]  Xi Chen,et al.  Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells , 2005, Molecular and Cellular Biology.

[50]  M. Yen,et al.  Isolation of Multipotent Cells from Human Term Placenta , 2005, Stem cells.

[51]  Y. Ishikawa,et al.  EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12) , 2005, Genes, chromosomes & cancer.